Evidence map›Paper›PMID 35197840›Full record

ReviewFrontiers in aging neuroscience2022

The Impact of Disease Registries on Advancing Knowledge and Understanding of Dementia Globally.

Shimaa A Heikal, Mohamed Salama, Yuliya Richard, Ahmed A Moustafa, Brian Lawlor

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in aging neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 4 countries.

Shimaa A HeikalInstitute of Global Health and Human Ecology (IGHHE), The American University in Cairo (AUC), New Cairo, Egypt.
Mohamed SalamaInstitute of Global Health and Human Ecology (IGHHE), The American University in Cairo (AUC), New Cairo, Egypt.
Yuliya RichardBlue Horizon Counseling Services, Sydney, NSW, Australia.
Ahmed A MoustafaSchool of Psychology, Faculty of Society and Design, Bond University, Gold Coast, QLD, Australia.
Brian LawlorTrinity College Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland.
American University in Cairo · EGMansoura University · EGTrinity College Dublin · IEUniversity of Johannesburg · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To help address the increasing challenges related to the provision of dementia care, dementia registries have emerged around the world as important tools to gain insights and a better understanding of the disease process. Dementia registries provide a valuable source of standardized data collected from a large number of patients. This review explores the published research relating to different dementia registries around the world and discusses how these registries have improved our knowledge and understanding of the incidence, prevalence, risk factors, mortality, diagnosis, and management of dementia. A number of the best-known dementia registries with high research output including SveDem, NACC, ReDeGi, CREDOS and PRODEM were selected to study the publication output based on their data, investigate the key findings of these registry-based studies. Registries data contributed to understanding many aspects of the disease including disease prevalence in specific areas, patient characteristics and how they differ in populations, mortality risks, as well as the disease risk factors. Registries data impacted the quality of patients' lives through determining the best treatment strategy for a patient based on previous patient outcomes. In conclusion, registries have significantly advanced scientific knowledge and understanding of dementia and impacted policy, clinical practice care delivery.

Indexed as

Alzheimer’s disease (AD)dementiadementia datasetsdementia prevalencedementia treatmentdisease registries

Identifiers

PMID35197840
PMCPMC8859161
OpenAlexW4210617790

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.